Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

428 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Antilipemics: from prevention to protection].
Bordet R, Gelé P, Deplanque D, Duriez P. Bordet R, et al. Therapie. 2003 Jan-Feb;58(1):69-76. doi: 10.2515/therapie:2003010. Therapie. 2003. PMID: 12822203 Review. French.
Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment.
Deplanque D, Gelé P, Pétrault O, Six I, Furman C, Bouly M, Nion S, Dupuis B, Leys D, Fruchart JC, Cecchelli R, Staels B, Duriez P, Bordet R. Deplanque D, et al. Among authors: bordet r. J Neurosci. 2003 Jul 16;23(15):6264-71. doi: 10.1523/JNEUROSCI.23-15-06264.2003. J Neurosci. 2003. PMID: 12867511 Free PMC article.
Peroxisome proliferator activated receptors and stroke.
Fruchart JC, Bordet R, Duriez P. Fruchart JC, et al. Among authors: bordet r. Curr Atheroscler Rep. 2003 Sep;5(5):331-2. doi: 10.1007/s11883-003-0001-6. Curr Atheroscler Rep. 2003. PMID: 12911841 No abstract available.
The neuroprotective effect of the antioxidant flavonoid derivate di-tert-butylhydroxyphenyl is parallel to the preventive effect on post-ischemic Kir2.x impairment but not to post-ischemic endothelial dysfunction.
Pétrault O, Bastide M, Cotelle N, Gelé P, Gautier S, Laprais M, Vamecq J, Duriez P, Bordet R. Pétrault O, et al. Among authors: bordet r. Naunyn Schmiedebergs Arch Pharmacol. 2004 Nov;370(5):395-403. doi: 10.1007/s00210-004-0966-x. Epub 2004 Oct 19. Naunyn Schmiedebergs Arch Pharmacol. 2004. PMID: 15502971
Increased susceptibility of low-density lipoprotein to ex vivo oxidation in mice transgenic for human apolipoprotein B treated with 1 melatonin-related compound is not associated with atherosclerosis progression.
Tailleux A, Gozzo A, Torpier G, Martin-Nizard F, Bonnefont-Rousselot D, Lemdani M, Furman C, Foricher R, Chevé G, Yous S, Micard F, Bordet R, Gardes-Albert M, Lesieur D, Teissier E, Fruchart JC, Fiévet C, Duriez P. Tailleux A, et al. Among authors: bordet r. J Cardiovasc Pharmacol. 2005 Sep;46(3):241-9. doi: 10.1097/01.fjc.0000175232.11079.7e. J Cardiovasc Pharmacol. 2005. PMID: 16116326
428 results